# Stembanc Inc – FDA Inspection, Feb 12, 2014

Source: https://www.keypedia.com/records/fda_inspections/stembanc-inc/05432b6a-b44b-4c03-b2c3-a50e23f7025e
Source feed: FDA_Inspections

> FDA inspection 862242 of Stembanc Inc, February 12, 2014. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 1271. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 862242
- Company Name: Stembanc Inc
- Inspection Date: 2014-02-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 6

## Related Documents

- FDA Inspection 1242190 - 2024-06-06
- FDA Inspection 1153328 - 2021-09-23
- [FDA Inspection 814359 - 2013-02-04](https://www.keypedia.com/records/fda_inspections/stembanc-inc/1c138f34-1dd3-4c20-920b-483c97e6c875)
- [FDA Inspection 659051 - 2010-04-27](https://www.keypedia.com/records/fda_inspections/stembanc-inc/59b7f972-fe8b-4f6d-8966-0d61d4db73b9)
- [FDA Inspection 596205 - 2009-08-31](https://www.keypedia.com/records/fda_inspections/stembanc-inc/9b31a0a8-3cb3-44f7-9be2-7760ef9083e7)

Company: https://www.keypedia.com/companies/stembanc-inc/ad32a63d-5cde-422f-b60f-e7e1d3e81799

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d